Le Lézard
Classified in: Health
Subject: SVY

Sequencing Of Stevia Plant Genome Revealed For The First Time By PureCircle Stevia Institute At The International Congress Of Nutrition


BUENOS AIRES, Argentina, Oct. 19, 2017 /CNW/ -- For the first time, scientists have completed the sequencing of the stevia plant genome. Lead scientists from PureCircle Stevia Institute and KeyGene have unveiled this major breakthrough in research showing the annotated, high-quality genome sequences of three stevia cultivars.

This achievement provides a better understanding of key enzyme groups used by the stevia plant to produce the steviol glycosides giving stevia its characteristic sweet taste. To enable acceleration of the traditional breeding of the stevia plant, researchers identified several million potentially new markers in the assembled genomes.

PureCircle's non-GMO agriculture program is strengthened by these cutting-edge findings. The research helps facilitate optimization of the levels of the best-tasting steviol glycosides, including improvements in the levels of the well-known minor glycosides, Reb D and Reb M.

The data has been integrated into CropPedia, a comprehensive bioinformatics platform developed by KeyGene for visualization and analytics of all available genomic, transcriptomic and metabolomic stevia datasets. CropPedia enables chemists, biochemists, geneticists and agronomists to better understand the steviol glycoside biosynthesis pathways, and to rapidly create improved stevia varieties using traditional breeding practices.

Stevia is a plant-based, zero-calorie sweetener which has been approved by all major regulatory authorities globally for use in foods and beverages in over 150 countries.

Optimized stevia ingredients developed as a result of this research will enable deeper reductions in sugar and calorie content of foods and beverages, as well as superior tasting products. This greatly benefits consumers around the world by helping them meet dietary guidelines calling for reductions in sugar and calorie intake for improved health.

"PureCircle is committed to strengthening the understanding of the stevia leaf," said Avetik Markosyan, Vice President, Head of Group Research and Development at PureCircle. "These findings provide strategic enhancements to our breeding and agronomy programs, as well as tremendous utility for scientists, farmers and developers working with stevia as a non-GMO ingredient."

"Having a single high-quality reference genome is generally considered a major step forward for newly domesticated crops, such as stevia," said Arjen van Tunen, CEO of KeyGene. "We have surpassed this benchmark with three independent reference genomes for stevia. This comprehensive understanding of the complexities of the stevia genome will directly translate to high?value, improved stevia varieties."

"Being an industry leader, agronomic research is an investment PureCircle values highly," said Faith Son, Vice President, Head of Marketing and Innovation at PureCircle. "This is indeed the stevia leaf's next step towards creating a clearer path to great taste and understanding all of the immense benefits the plant contains for the global food and beverage industry, as well as consumers."

PureCircle Ltd. and The Coca-Cola Company co-funded this research.

 

SOURCE PureCircle Stevia Institute


These press releases may also interest you

at 17:00
GBLT Corp. ("GBLT" or the "Company") announces that minority shareholders have approved the voluntary delisting (the "Delisting") of the common shares of the Company from the TSX Venture Exchange ("TSXV").  Approval for the delisting was received at...

at 17:00
L.A. Care Health Plan and Blue Shield of California Promise Health Plan today held a grand opening ceremony for their Community Resource Center (CRC) in West Los Angeles (West L.A.) at 11173 W. Pico Blvd in Los Angeles....

at 16:55
Veterinary Management Groups (VMG) is proud to...

at 16:45
Cronos Group Inc. ("Cronos" or the "Company") will hold its 2024 Annual Meeting of Shareholders on Thursday, June 20, 2024, at 11:00 a.m. ET. Cronos will be conducting the meeting in a virtual-only format via live audio webcast. Registered...

at 16:30
Today, the Biden-Harris Administration released a final rule under Section 1557, the core nondiscrimination provision of the Affordable Care Act. This groundbreaking rule marks a critical step in protecting access to health care and coverage for...

at 16:14
eNeura, a pioneering leader in therapeutic solutions, proudly announces a monumental milestone in its journey towards revolutionizing migraine treatment. With unwavering commitment to innovation and patient well-being, eNeura has already reached...



News published on and distributed by: